Acute changes in n-terminal pro-b-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure

American Journal of Cardiology

Volumn 107, Issue 8, 2011, Pages 1191-1195

  Michtalik, Henry J ^a   Yeh, Hsin Chieh ^a,b   Campbell, Catherine Y ^a   Haq, Nowreen ^a   Park, Haeseong ^b   Clarke, William ^a   Brotman, Daniel J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATININE; FUROSEMIDE;

ADULT; AGED; ARTICLE; COMORBIDITY; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

AGED; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MARYLAND; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PATIENT READMISSION; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SURVIVAL RATE;

EID: 79953253143     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.12.018     Document Type: Article

References (17)

1. S. Anwaruddin, D.M. Lloyd-Jones, A. Baggish, A. Chen, D. Krauser, R. Tung, C. Chae, and J.L. Januzzi Jr Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study J Am Coll Cardiol 47 2006 91 97 (Pubitemid 43005170)
2. G.W. Moe, J. Howlett, J.L. Januzzi, H. Zowall Canadian Multicenter Improved Management of Patients With Congestive Heart Failure (IMPROVE-CHF) Study Investigators N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: Primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study Circulation 115 2007 3103 3110 (Pubitemid 46956499)
3. P. Bettencourt, A. Azevedo, J. Pimenta, F. Frioes, S. Ferreira, and A. Ferreira N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients Circulation 110 2004 2168 2174 (Pubitemid 39372496)
4. S. Di Somma, L. Magrini, V. Pittoni, R. Marino, A. Mastrantuono, E. Ferri Italian RED Study Investigators In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study Crit Care 14 2010 R116
5. K.B. Shah, W.J. Kop, R.H. Christenson, D.B. Diercks, D. Kuo, S. Henderson, K. Hanson, and C.R. deFilippi Post-discharge changes in NT-proBNP and quality of life after acute dyspnea hospitalization as predictors of one year outcomes Clin Biochem 43 2010 1405 1410
6. A.H. Wu Serial testing of B-type natriuretic peptide and NT pro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results Am Heart J 152 2006 828 834 (Pubitemid 44632969)
7. A. Bhardwaj, and J.L. Januzzi Jr Natriuretic peptide-guided management of acutely destabilized heart failure: rationale and treatment algorithm Crit Pathw Cardiol 8 2009 146 150
8. D. Logeart, G. Thabut, P. Jourdain, C. Chavelas, P. Beyne, F. Beauvais, E. Bouvier, and A.C. Solal Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure J Am Coll Cardiol 43 2004 635 641 (Pubitemid 38229537)
9. S.W. Waldo, J. Beede, S. Isakson, S. Villard-Saussine, J. Fareh, P. Clopton, R.L. Fitzgerald, and A.S. Maisel Pro-B-type natriuretic peptide levels in acute decompensated heart failure J Am Coll Cardiol 51 2008 1874 1882 (Pubitemid 351615249)
10. R.J. O'Brien, I.B. Squire, B. Demme, J.E. Davies, and L.L. Ng Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF Eur J Heart Fail 5 2003 499 506 (Pubitemid 37021644)
11. P. Bettencourt, and J.L. Januzzi Jr Amino-terminal pro-B-type natriuretic peptide testing for inpatient monitoring and treatment guidance of acute destabilized heart failure Am J Cardiol 101 2008 67 71
12. P. Kubler, J. Petruk-Kowalczyk, J. Majda, K. Reczuch, W. Banasiak, and P. Ponikowski Persistent high NT-proBNP concentration as a negative prognostic factor in patients with decompensated heart failure Kardiol Pol 64 2006 250 258
13. A. Bayes-Genis, L. Lopez, E. Zapico, C. Cotes, M. Santalo, J. Ordonez-Llanos, and J. Cinca NT-proBNP reduction percentage during admission for acutely decompensated heart failure predicts long-term cardiovascular mortality J Card Fail 11 2005 S3 S8
14. I.S. Anand, L.D. Fisher, Y.T. Chiang, R. Latini, S. Masson, A.P. Maggioni, R.D. Glazer, G. Tognoni, J.N. Cohn Val-HeFT Investigators Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT) Circulation 107 2003 1278 1283 (Pubitemid 36314411)
15. S. Masson, R. Latini, I.S. Anand, S. Barlera, L. Angelici, T. Vago, G. Tognoni, J.N. Cohn Val-HeFT Investigators Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial) J Am Coll Cardiol 52 2008 997 1003
16. S. Anwaruddin, D.M. Lloyd-Jones, A. Baggish, A. Chen, D. Krauser, R. Tung, C. Chae, and J.L. Januzzi Jr Parameters for the Appropriate Definition of Hospital Readmissions [Homepage on Internet] 2008 Agency for Healthcare Research and Quality Rockville, MD www.ahrq.gov/qual/kt/workshop1208/mcbride3.htm Accessed August 8, 2010
17. M. Pfisterer, P. Buser, H. Rickli, M. Gutmann, P. Erne, P. Rickenbacher, A. Vuillomenet TIME-CHF Investigators BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) Randomized Trial JAMA 301 2009 383 392